SCM
AGN

Steadfast Capital Management’s Allergan plc AGN Stock Holding History

Steadfast Capital Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-122,683
Closed -$29.3M – 63
2017
Q1 		$29.3M Buy
+122,683
New +$28.6M 0.57% 40
2016
Q4 		– Sell
-464,451
Closed -$107M – 61
2016
Q3 		$107M Buy
464,451
+100,579
+28% +$24.6M 1.91% 23
2016
Q2 		$84.1M Buy
363,872
+85,145
+31% +$19.6M 2.13% 18
2016
Q1 		$74.7M Sell
278,727
-417,337
-60% -$119M 1.79% 18
2015
Q4 		$218M Sell
696,064
-185,756
-21% -$55.3M 4.16% 6
2015
Q3 		$240M Sell
881,820
-922,272
-51% -$283M 4.8% 4
2015
Q2 		$547M Sell
1,804,092
-567,784
-24% -$169M 8.1% 1
2015
Q1 		$706M Buy
2,371,876
+1,608,911
+211% +$459M 9.85% 1
2014
Q4 		$196M Sell
762,965
-427,798
-36% -$107M 3.07% 9
2014
Q3 		$287M Sell
1,190,763
-550,545
-32% -$123M 4.86% 3
2014
Q2 		$388M Buy
1,741,308
+51,753
+3% +$10.7M 6.32% 3
2014
Q1 		$348M Buy
1,689,555
+560,331
+50% +$111M 7.41% 1
2013
Q4 		$190M Buy
+1,129,224
New +$177M 4.35% 5

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Steadfast Capital Management's AGN Position: Q2 2017 in Review

Steadfast Capital Management sold out of Allergan plc (AGN) in Q2 2017, closing a stake of 122,683 shares — an estimated $29.3M sold.

Steadfast Capital Management first reported a position in AGN in Q4 2013 and held it in 13 quarters. The position peaked at $706M in Q1 2015. 1,115 funds tracked by Wall St. Rank hold AGN as of Q2 2017.

  • Steadfast Capital Management reported no remaining Allergan plc position as of Q2 2017 after selling out during the quarter.
  • Steadfast Capital Management sold 122,683 Allergan plc shares in Q2 2017, an estimated $29.3M.
  • Steadfast Capital Management first reported a position in Allergan plc in Q4 2013 and held it in 13 quarters.
  • Steadfast Capital Management's Allergan plc position peaked at $706M in Q1 2015.
  • 1,115 funds tracked by Wall St. Rank held Allergan plc as of Q2 2017.

Based on Steadfast Capital Management's 13F filing for Q2 2017, filed 14 Aug 2017.